GLI3 and Hyperkeratosis: After Oxa treatment, Gli3+/– mice had attenuated epidermal and dermal thickening with decreased hyperkeratosis and parakeratosis compared with WT mice (Figure 2H), and serum IgE levels were significantly decreased (Figure 2I).